Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Active not recruiting 3Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 16OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

tislelizumab 12Capecitabine 8Carboplatin 5Surgical Procedures, Operative 4Oxaliplatin 4Drug Therapy 4apatinib 3Paclitaxel 3Cisplatin 3Bevacizumab 3ivarmacitinib 2anlotinib 2Standard of Care 2Radiotherapy 2Radiation 2Methods 2Melphalan 2Low-Level Light Therapy 2Letrozole 2Interleukin-2 2Injections 2Immunotherapy 2Cryotherapy 2zanubrutinib 1trastuzumab deruxtecan 1toripalimab 1surufatinib 1sintilimab 1pyrotinib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Radiotherapy, Intensity-Modulated × Clear all
NCT06775756 2025-01-15

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

Fujian Cancer Hospital

Phase 3 Not yet recruiting
474 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡